Merck & Co., Inc. Research And Development Expense

• Merck & Co., Inc. showed a decrease of -12.0% in Research And Development Expense from 2024 to 2025.
• This data is from Merck & Co., Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), Merck & Co., Inc.'s Research And Development Expense has grown by 228.6%.
• Historical annual values: Fiscal year 2025: $15.79 billion | Fiscal year 2024: $17.94 billion | Fiscal year 2023: $30.53 billion | Fiscal year 2022: $13.55 billion | Fiscal year 2021: $12.25 billion | Fiscal year 2020: $13.40 billion | Fiscal year 2019: $9.72 billion | Fiscal year 2018: $9.75 billion | Fiscal year 2017: $10.34 billion | Fiscal year 2016: $10.26 billion | Fiscal year 2015: $6.70 billion | Fiscal year 2014: $7.18 billion | Fiscal year 2013: $7.50 billion | Fiscal year 2012: $8.17 billion | Fiscal year 2011: $8.47 billion | Fiscal year 2010: $11.11 billion | Fiscal year 2009: $5.85 billion | Fiscal year 2008: $4.81 billion.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026